Brainsway Ltd.【BWAY】

時価総額

PER

非侵襲的な脳刺激治療の最大手。Deep TMSプラットフォームとHコイルを用いた治療機器を展開。2019年4月16日のNASDAQ上場や2024年11月5日のADS・ワラント私募、Valorが17.69%保有。米国・イスラエル中心に展開。

	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Net profit (loss) and total comprehensive profit (loss)	-10	-5	-6	-13	-4	3
Depreciation and amortization	2	1	1	1	0	1
Depreciation of leased systems	-	1	1	1	1	1
Impairment and disposal of inventory and system components	-	-	-	-	1	2
Finance expenses (income), net	-	-	-	-	-	2
Cost of share-based payment	1	1	2	1	0	1
Income taxes	0	0	0	0	0	1
Total adjustments to reconcile loss	6	4	6	4	2	3
Increase in inventory	-	-	-	-4	-1	-1
Decrease (increase) in trade receivables	-3	-0	-1	1	1	-1
Decrease (increase) in other current assets	-	-	-	-	-0	2
Increase (decrease) in trade payables	0	-1	0	-	-0	2
Increase in other accounts payable	-0	1	1	0	0	0
Increase in deferred revenues	-	-	2	1	2	0
Total changes in asset and liability	-	0	1	-1	2	2
Interest paid	0	0	0	0	0	0
Interest received	0	0	0	1	2	3
Income taxes paid	1	0	0	0	0	1
Total cash received during the year	-	-0	-0	1	1	2
Net cash provided by (used in) operating activities	-7	-1	1	-10	1	10
Proceeds from disposal (purchase) of property and equipment and system components, net	-	-	-	-	-2	-4
Proceeds from lease assets	-	-	-	-	-	0
Proceeds from short-term bank deposits	-	-	-	-	-	35
Investment in long-term deposits, net	-	-	0	-0	-0	-1
Net cash provided by (used in) investing activities	-2	-2	-42	42	-37	30
Repayment of liability in respect of research and development grants	-	-	-	-	-	1
Repayment of lease liabilities	-	-	-	-	-	0
Exercise of share options	-	-	-	-	-	0
Issuance of warrants liability	-	-	-	-	-	3
Proceeds from issuance of shares, net	-	-	-	-	-	16
Net cash provided by (used in) financing activities	22	-1	42	-2	-1	18
Exchange rate differences on balance of cash and cash equivalents	-0	0	-0	-0	0	-0
Increase (decrease) in cash and cash equivalents	13	-5	-0	31	-37	59
Right-of-use asset recognized with corresponding lease liability	-	-	-	-	-	6